Harriet Lefton

About the Author Harriet Lefton

Harriet originates from the UK where she worked as a journalist specializing in the metal markets. She graduated from the University of Cambridge before becoming a qualified UK lawyer.

3 Canadian Energy Giants Worth Betting On Now, Says RBC Capital  

Energy firms are some of the biggest players on the Canadian stock exchange. Here we turned to RBC Capital to pinpoint three of …

First Majestic Signs Over Potential 100% La Joya Stake To Silver Dollar

First Majestic Silver (AG) has now executed a definitive option agreement granting Silver Dollar Resources a potential 100% interest in First Majestic’s La Joya silver-copper-gold …

Tilray Plunges 10% As Canadian Cannabis Market Remains Under Pressure

Shares in Canadian pharmaceutical and cannabis company Tilray (TLRY) plunged 10% in Monday’s after-hours trading on mixed second quarter earning results. The stock …

Novavax Rises 5% On Earnings; $2B Covid-19 Vaccine Funding

Shares in Novavax (NVAX) rose 5% in Monday’s trading after the late-stage biotech announced positive second quarter earning results. However the stock subsequently …

Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study

Shares in Pluristem Therapeutics (PSTI) rose 6% in Monday’s pre-market trading after Germany’s health regulatory agency, the Paul Ehrlich Institute (PEI), approved Pluristem’s …

PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined

PTC Therapeutics (PTCT) has announced that the US Food and Drug Administration (FDA) has approved Evrysdi (risdiplam), the first at-home, orally administered treatment …

Regeneron Prices $1.25B Public Offering; Analyst Cautious On Valuation

Regeneron Pharmaceuticals (REGN) has now announced the pricing of an underwritten offering of $1.250 billion aggregate principal amount of senior unsecured notes due …

Cisco Completes ThousandEyes Deal; Analyst Warns Of Growth Headwinds

Cisco (CSCO) has announced that it has completed the acquisition of ThousandEyes. The deal for the internet and cloud intelligence platform, worth a reported …

Roper Looking To Snap Up Vertafore For $5.5 Billion- Report

Roper Technologies Inc (ROP) is in talks to acquire private equity-owned insurance software vendor Vertafore Inc for close to $5.5 billion, according to …

Bristol Myers Reports Significant Survival Improvement For Rare Lung Cancer

Bristol Myers Squibb (BMY) has announced that Opdivo (nivolumab) plus Yervoy (ipilimumab) demonstrated a significant improvement in overall survival (OS) in patients with previously untreated, unresectable …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts